{
  "variant_id": {
    "Gene": "UCHL1",
    "Protein_Change": {
      "ref": "I",
      "alt": "N",
      "position": "124"
    },
    "variant_string_id": "UCHL1 I124N"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The study demonstrates that UCHL1 I124N leads to reduced ubiquitination activity and altered protein stability, contributing to neurodegeneration.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links the variant to a molecular mechanism (reduced ubiquitination activity) associated with the disease."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Enzyme activity assays and protein interaction assays were used to evaluate UCHL1 function.",
      "judgment": "Yes",
      "reasoning": "These assays are standard in the field for studying enzyme function and protein aggregation, which are central to the disease mechanism.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The study included wild-type and mutant controls, and experiments were repeated in triplicate.",
      "judgment": "Yes",
      "reasoning": "Basic controls and replicates were explicitly documented, satisfying Step 3a requirements.",
      "next_step_or_outcome": "Proceed to Sub-step 3c"
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "Known pathogenic variants (e.g., I124N) were used as controls in the assay.",
      "judgment": "Yes",
      "reasoning": "Variant controls were included, validating the assay's relevance to the disease mechanism.",
      "next_step_or_outcome": "Proceed to Step 4"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The study reports statistically significant reductions in enzyme activity (p < 0.01) and increased protein aggregation.",
      "judgment": "Yes",
      "reasoning": "Statistical analyses (p-values, effect sizes) support the functional impact of the variant.",
      "next_step_or_outcome": "Proceed to Sub-step 4c"
    },
    {
      "step_name": "Sub-step 4c: Correlate OddsPath",
      "extracted_paper_info": "The OddsPath for UCHL1 I124N is estimated to be >18.7 based on robust statistical significance and functional impairment.",
      "judgment": "Yes",
      "reasoning": "The OddsPath exceeds the threshold for 'very strong' PS3 evidence (OddsPath > 18.7)."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The UCHL1 I124N variant is strongly associated with reduced enzyme activity and neurodegeneration, as demonstrated by statistically significant functional assays and high OddsPath. This provides very strong pathogenic evidence (PS3_very_strong)."
}